ReviewOne health outlook2025
A review of zoonotic chlamydiae species in Africa: assessing their burden and potential impact through One Health perspective.
Review in One health outlook, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Epidemiology and Genetic Diversity ofPathogens (Basel, Switzerland) · 2025Article
- The impact of parasitic diseases on dromedary camel (Frontiers in veterinary science · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlamydia species, a group of obligate intracellular Gram-negative bacteria, affect humans, livestock, companion animals, and wildlife, with infections ranging from asymptomatic to severe depending on host species and strain. Diagnosis can be difficult due to mild lesions or co-infections. Because Chlamydiaceae infect multiple hosts, a One Health approach, integrating human, animal, and environmental health is essential for effective control and prevention. C. trachomatis remains endemic in many regions, while Chlamydia pneumoniae is implicated in community-acquired pneumonia. C. abortus threatens livestock and people in pastoralist communities. Other species, including C. caviae, C. felis, C. muridarum, C. pecorum, and C. psittaci, cause high morbidity in animals, and many are zoonotic, posing risks to humans through cross-species transmission. Closely related Chlamydia-like bacteria also pose emerging threats in both human and animal populations. In Africa, diverse ecosystems facilitate frequent cross-species contacts that can drive disease emergence. Rapid urbanization, population growth, and widespread poverty increase transmission, while political instability and food insecurity reduce public health responses. As the continent faces a disproportionate burden of emerging and re-emerging infections, strengthening surveillance and targeted interventions is crucial. This review examines current knowledge on the transmission dynamics and public health implications of Chlamydiaceae species in African settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.